Menarini to acquire CellSearch in the US

Menarini has acquired US-based CellSearch CTC from US-based Janssen Diagnostics LLC through its subsidiary Menarini Silicon Biosystems. CellSearch’s portfolio includes the only instrument already approved by FDA and granted the CE mark capable of detecting circulating tumor cells in patients with cancer starting from a liquid biopsy. The CellSearch’s Huntingdon Valley site and R&D center will be included in the transaction. Menarini already has a product for this type of diagnosis, that is DEPArray technology, assessing liquid and solid biopsies and isolating circulating tumor cells. DEPArray will be combined with the CellSearch’s technology, which enables to retrieve and enumerate such cells. The parties have not provided the financial details of the transaction.
(Source Menarini)